Clinical Trials Directory

Trials / Terminated

TerminatedNCT01349426

Ligasure II: Standard Stapling Versus Ligasure

Standard Stapling Technique Versus Bipolar Fusion (With The Ligasure Impact and Force Triad Generator) To Complete The Fissure During Major Lung Resection: A Prospective Randomized Controlled Trial

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
172 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Surgical staplers have become standard for ligation, division, resection, anastomosis and closure in many surgical procedures. Staplers are utilized in thoracic surgery routinely for pulmonary parenchymal resection and closure, ligation of vessels and bronchi. In addition, closure of incomplete fissure/s is a frequent need in pulmonary surgery. Although generally safe and efficacious, staplers and staple loads are expensive, and can result in micro air leaks. The LigaSure Vessel Sealing System presents as a potentially faster and less expensive alternative to staplers. The LigaSure Vessel sealing system utilizes a combination of heat generated via bi-polar radiofrequency energy and precise jaw pressure to denature the collagen and elastin in tissue and blood vessels. The newly released Force Triad Generator and the Impact, a 10 mm jaw sealing device (Ligasure system, COVIDIEN Society) may offer improved performance in terms of tissue sticking due to an improved sealing algorithm, and to the jaw configuration of the Impact. The study main objective is to compare the quality of parenchymal pneumostasis after fissure closure achieved with staplers vs that achieved with LigaSure.

Conditions

Interventions

TypeNameDescription
DEVICELigaSure Force Triad Vessel Sealing SystemQuality of parenchymal pneumostasis comparison after fissure closure: LigaSure vs automatic staplers

Timeline

Start date
2010-09-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2011-05-06
Last updated
2015-07-28

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01349426. Inclusion in this directory is not an endorsement.